Vertaile menetelmiä
Tarkastele valitsemiasi menetelmiä rinnakkain; eroavat rivit korostetaan.
| Yale-Brown Obsessive Compulsive Scale (Y-BOCS)× | Positiivisten ja negatiivisten oireiden asteikko (PANSS)× | |
|---|---|---|
| Tieteenala | Psykiatria | Psykiatria |
| Menetelmäperhe | Process / pipeline | Process / pipeline |
| Syntyvuosi≠ | 1989 | 1987 |
| Kehittäjä≠ | Wayne K. Goodman | Stanley R. Kay |
| Tyyppi | Clinician-administered rating scale | Clinician-administered rating scale |
| Alkuperäislähde≠ | Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., ... & Charney, D. S. (1989). The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Archives of General Psychiatry, 46(11), 1006–1011. DOI ↗ | Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261–276. DOI ↗ |
| Rinnakkaisnimet≠ | Y-BOCS, YBOCS | PANSS |
| Liittyvät | 3 | 3 |
| Tiivistelmä≠ | The Y-BOCS is a 10-item clinician-administered scale designed to assess the severity of obsessive-compulsive disorder (OCD) symptoms in adolescents and adults. Developed by Goodman and colleagues in 1989, it has become the gold standard severity measure and primary outcome tool in OCD research and clinical trials. The scale is widely used in psychiatric settings to track symptom burden over time and evaluate treatment response. | The PANSS is a 30-item clinician-administered scale designed to measure the presence and severity of positive symptoms (delusions, hallucinations, disorganization), negative symptoms (affective flattening, alogia, avolition), and general psychopathology in schizophrenia and related psychotic disorders. Developed by Kay, Fiszbein, and Opler in 1987, the PANSS has become the standard rating scale in schizophrenia research, antipsychotic medication trials, and clinical monitoring. It provides comprehensive assessment across three symptom domains and yields a total score reflecting overall disease severity. |
| ScholarGateAineisto ↗ |
|
|